Mycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia

QR Code

Mycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia

Aim: Immune restoration disease (IRD) associated with Mycobacterium tuberculosis parallels the reconstitution of a pathogen-specific Th1 response. However, it is not clear whether humoral responses to M. tuberculosis antigens also rise, or whether antibody levels predict IRD. Here, humoral immunity...

Full description

Bibliographic Details
Main Authors:	Sumatoh, H., Oliver, B., Kumar, M., Elliott, J., Vonthanak, S., Vun, M., Singh, S., Agarwal, U., Kumar, A., Tan, H., Kamarulzaman, A., Yunihastuti, E., Saraswati, H., Price, Patricia
Format:	Journal Article
Published:	2011
Online Access:	http://hdl.handle.net/20.500.11937/13023

Similar Items

Mycobacterial immune restoration disease: One symphony, two or many?
by: Price, Patricia
Published: (2012)

Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART
by: Yunihastuti, E., et al.
Published: (2011)

TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease
by: Tan, D., et al.
Published: (2011)

Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis
by: Tan, D., et al.
Published: (2008)

Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease
by: Lim, A., et al.
Published: (2008)

Interferon-? and IL-5 production correlate directly in HIV patients Co-infected with mycobacterium tuberculosis with or without immune restoration disease
by: Oliver, B., et al.
Published: (2010)

The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis
by: Affandi, J., et al.
Published: (2013)

Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2010)

The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2011)

Characteristics of natural killer cells in Malaysian HIV patients presenting with immune restoration disease after ART
by: Tan, D., et al.
Published: (2010)

Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with mycobacterium tuberculosis
by: Price, Patricia, et al.
Published: (2012)

Immune restoration disease complicating antiretroviral therapy in patients with HIV infection: Implications and solutions
by: French, M., et al.
Published: (2008)

Immune restoration diseases reflect diverse immunopathological mechanisms
by: Price, Patricia, et al.
Published: (2009)

Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy
by: Lee, S., et al.
Published: (2014)

Tuberculosis associated immune reconstitution inflammatory syndrome in patients infected with HIV: meningitis a potentially life threatening manifestation
by: Agarwal, U., et al.
Published: (2012)

Naive and Memory CD4+ T Cells Are Differentially Affected in Indonesian HIV Patients Responding to ART
by: Tanaskovic, S., et al.
Published: (2016)

Increased plasma CXCL10 may be a marker of increased risk of immune restoration disease associated with nonviral pathogens
by: Oliver, B., et al.
Published: (2012)

Increased proportions of dendritic cells and recovery of IFNγ responses in HIV/HCV co-infected patients receiving ART
by: Saraswati, H., et al.
Published: (2015)

Searching for an immunogenetic factor that will illuminate susceptibility to non-tuberculous mycobacterial disease
by: Affandi, J., et al.
Published: (2013)

Susceptibility to non-tuberculous mycobacterial disease is influenced by rs1518111 in IL10
by: Halstrom, S., et al.
Published: (2017)

Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy
by: Oliver, B., et al.
Published: (2013)

Periportal CD4+ Cell Infiltration Increases in HIV/Hepatitis C Virus–Coinfected Patients Commencing ART, Whereas CD8+ Cells Clear From the Liver
by: Gani, R., et al.
Published: (2014)

The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy
by: Lee, S., et al.
Published: (2017)

Is Pulmonary non-Tuberculous Mycobacterial Disease Linked with a High Burden of Latent Cytomegalovirus?
by: Amran, F., et al.
Published: (2016)

Antibody and B-cell responses may control circulating lipopolysaccharide in patients with HIV infection
by: Lim, A., et al.
Published: (2011)

Plasma biomarkers in the prediction and diagnosis of tuberculosis-associated immune reconstitution inflammatory syndrome
by: French, M., et al.
Published: (2011)

Age and height predict neuropathy risk in patients with HIV prescribed stavudine
by: Cherry, C., et al.
Published: (2009)

Immunological and epidemiological factors affecting candidiasis in HIV patients beginning antiretroviral therapy in an Asian clinic
by: Wulandari, E., et al.
Published: (2017)

Tuberculosis (TB)-associated immune reconstitution inflammatory syndrome in TB-HIV co-infected patients in Malaysia: prevalence, risk factors, and treatment outcomes
by: Tan, H.Y., et al.
Published: (2014)

Do Cytomegalovirus Antibody Levels Associate with Age-Related Syndromes in HIV Patients Stable on Antiretroviral Therapy?
by: Brunt, S., et al.
Published: (2016)

Multivariate immunoprofiling of individuals prone to non-tuberculous mycobacterial infection reveals T cell exhaustion and dysfunction
by: Ratnatunga, C., et al.
Published: (2016)

A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease
by: Halstrom, S., et al.
Published: (2017)

Immune reconstitution syndrome is not a single entity
by: Price, Patricia, et al.
Published: (2008)

Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.
by: Oliver, B., et al.
Published: (2012)

Development Of An Immune Tuberculosis Antibody Library: Monoclonal Antibody Generation For a-Crystalline Antigen
by: Hamidon, Nurul Hamizah
Published: (2017)

Characterization Of Recombinant Antibodies Targeting Hiv-1 Capsid Protein (P24): Towards The Development Of Antibody-Based Therapy Against Hiv/Aids
by: Mualif, Siti Aisyah
Published: (2017)

Robust interferon-a and IL-12 responses by dendritic cells are related to efficient CD4+ T-cell recovery in HIV patients on ART
by: Tan, D., et al.
Published: (2011)

Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy.
by: Marini, S., et al.
Published: (2016)

Llama antibody fragments have good potential for application as HIV Type 1 topical microbicides
by: Gorlani, A., et al.
Published: (2011)

An NK cell population lacking FcR? is expanded in chronically infected HIV patient
by: Zhou, J., et al.
Published: (2015)

Cannot write session to /tmp/vufind_sessions/sess_avm627mk20ejlkntu3a228ts4f